Beijing Tiantan Biological Products Co., Ltd. (SHA: 600161)
China
· Delayed Price · Currency is CNY
20.06
-0.16 (-0.79%)
Jan 3, 2025, 11:30 AM CST
Beijing Tiantan Biological Products Revenue
Beijing Tiantan Biological Products had revenue of 1.23B CNY in the quarter ending September 30, 2024, a decrease of -7.44%. This brings the company's revenue in the last twelve months to 5.23B, down -2.59% year-over-year. In the year 2023, Beijing Tiantan Biological Products had annual revenue of 5.18B with 21.57% growth.
Revenue (ttm)
5.23B
Revenue Growth
-2.59%
P/S Ratio
7.59
Revenue / Employee
1.08M
Employees
4,858
Market Cap
39.33B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.18B | 919.14M | 21.57% |
Dec 31, 2022 | 4.26B | 149.15M | 3.63% |
Dec 31, 2021 | 4.11B | 666.56M | 19.35% |
Dec 31, 2020 | 3.45B | 163.74M | 4.99% |
Dec 31, 2019 | 3.28B | 350.80M | 11.97% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
Jiangsu Hengrui Medicine | 26.00B |
WuXi AppTec | 38.50B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Aier Eye Hospital Group | 20.62B |
Shanghai United Imaging Healthcare | 10.93B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Beijing Wantai Biological Pharmacy Enterprise | 2.49B |